Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Interest Coverage Ratio: 2020-2025

Historic Interest Coverage Ratio for Apellis Pharmaceuticals (APLS) over the last 6 years, with Sep 2025 value amounting to 19.79.

  • Apellis Pharmaceuticals' Interest Coverage Ratio rose 624.49% to 19.79 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.79, marking a year-over-year increase of 129.00%. This contributed to the annual value of -4.08 for FY2024, which is 76.64% up from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Interest Coverage Ratio of 19.79 as of Q3 2025, which was up 762.95% from -2.98 recorded in Q2 2025.
  • In the past 5 years, Apellis Pharmaceuticals' Interest Coverage Ratio registered a high of 19.79 during Q3 2025, and its lowest value of -56.09 during Q3 2021.
  • Its 3-year average for Interest Coverage Ratio is -7.15, with a median of -7.54 in 2025.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first plummeted by 318.78% in 2021, then surged by 624.49% in 2025.
  • Quarterly analysis of 5 years shows Apellis Pharmaceuticals' Interest Coverage Ratio stood at -29.62 in 2021, then increased by 28.43% to -21.20 in 2022, then soared by 46.14% to -11.42 in 2023, then skyrocketed by 80.13% to -2.27 in 2024, then skyrocketed by 624.49% to 19.79 in 2025.
  • Its Interest Coverage Ratio was 19.79 in Q3 2025, compared to -2.98 in Q2 2025 and -7.54 in Q1 2025.